Matthew Boyd

Matthew Boyd

General Counsel at ENGENE THERAPEUTICS INC.

Net worth: 12 975 $ as of 30/06/2026

52 year
Consumer Services
Health Technology
Commercial Services

Profile

Matthew Boyd is Chief Regulatory Officer at enGene Therapeutics, Inc. starting in 2025.
Formerly, Mr. Boyd was Vice President-Regulatory Affairs at Albireo Pharma, Inc. and Head-Regulatory Affairs & Quality Assurance at Zambon Usa Ltd. Education includes an undergraduate degree from Philadelphia College of Pharmacy and an MBA from Kelley School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
16/06/2026 7,500 ( 0.01% ) 12 975 $ 30/06/2026

Matthew Boyd active positions

CompaniesPositionStart
ENGENE THERAPEUTICS INC. General Counsel 01/09/2024

Former positions of Matthew Boyd

CompaniesPositionEnd
ALBIREO PHARMA, INC. General Counsel -
General Counsel -
See the detail of Matthew Boyd's experience

Training of Matthew Boyd

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

8

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services